Delivery Order SPE2DB22D2206-SPE2DB25FEW66
Award Date
12/30/24
Potential Completion Date
12/31/24
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is a Delivery Order for the supply of 100 mg REMICADE vials. The contract has a ceiling value of $7,706.40 and runs through November 1, 2024. It is a Firm Fixed Price contract with no set-aside designation. AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, with a ceiling value of $83,272.77, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $95,007.09, is a delivery order for the supply of REMICADE 100 MG VIALS. The contract has no set-aside designation, indicating open competition.
AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier to various government agencies, particularly the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,536.08 Firm Fixed Price delivery order (Award ID: SPE2DB20D1100|SPE2DB25FZ36V) is for the supply of 4566598452 REMICADE 100 MG VIALS, with a completion date of December 4, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract award, valued at $78,531.28, is for the supply of REMICADE 100MG 20ML 1S, which are pharmaceutical products used in medical treatment. The contract does not have a set-aside designation, indicating open competition. As a major...
The U.S. Defense Logistics Agency (DLA) awarded a $3,327.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 100 mg Remicade vials. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
This federal contract award is for the procurement of REMICADE 100 MG VIALS by the Defense Logistics Agency (DLA) from AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,121.10 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of...
This federal contract award, valued at $10,275.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the provision of REMICADE 100 mg vials, a pharmaceutical product. The contract has a completion date of June 14, 2024 and is structured as a firm fixed-price delivery order.
Amerisourcebergen, a major pharmaceutical distribution company, holds two Indefinite Delivery Contracts (IDCs) with the DLA and the Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,064.64 firm-fixed-price delivery order is for 100 mg vials of the medication Remicade. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical division. The IDC, which runs through November 2026, enables the efficient procurement of a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of REMICADE 100 MG VIALS. The contract has a ceiling value of $35,458.10 and is a firm fixed price delivery order that runs through August 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...